Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Share-based compensation expense

Asset impairment and restructuring costs

Expected credit losses on financial assets and related charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Canopy Growth

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The firm operates through the following segments: Canada Cannabis, Rest-of-world Cannabis, Storz and Bickel, BioSteel, This Works, and Other. The Canada Cannabis segment includes the production, distribution, and sale of cannabis, hemp, and cannabis products in Canada. The Rest-of-world Cannabis segment focuses on production and sale of cannabis, hemp, and cannabis products internationally. The Storz and Bickel segment produces and sells vaporizers. The BioSteel segment refers to the sale of consumer packaged goods including sports nutrition beverages, hydration mixes, proteins, and other specialty nutrition products. The This Works segment includes the production and sale of beauty, skincare, wellness, and sleep products, some of which have been blended with hemp-derived CBD isolate. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Canopy Growth Corporation's (TSX:WEED, NYSE:CGC) plan to fast-track its entry into the US cannabis market is the first clear path for multi-state operator (MSO) uplisting, according to analysts at Stifel GMP.  On Monday, the Canadian cannabis producer announced plans to create a holding company, Canopy USA LLC, to speed up its entry into the US cannabis market, the largest and fastest-growing cannabis market in the world.

Canopy Growth's plan to fast-track US entry 'the first clear path for MSO uplisting,' Stifel analysts say

Canopy Growth Company surged more than 25% on news of an acquisition that could lead to full-scale access of the US market

Is This The Bottom For Canopy Growth Corporation?

SMITHS FALLS, ON , Oct. 25, 2022 /PRNewswire/ - Canopy Growth Corporation ("Canopy" or the "Company") (TSX: WEED) (NASDAQ: CGC) and Canopy USA, LLC ("Canopy USA ") today announced that each of the Company and Canopy USA has filed an early warning report under National Instrument 62-103 - The Early Warning System and Related Take-Over Bid and Insider Reporting Issues in connection with the Company's direct and indirect disposition of, and Canopy USA's direct and indirect acquisition of beneficial ownership of: (i) 38,890,570 exchangeable shares (the "Exchangeable Shares") in the capital of TerrAscend Corp. ("TerrAscend"); (ii) an option to acquire 1,072,450 common shares (the "Common Shares") in the capital of TerrAscend for an aggregate exercise price of $1.00 (the "TerrAscend Option"); (ii) 2,152,733 Common Share purchase warrants (the "Warrants") with an exercise price of C$3.74 per Common Share (the "TerrAscend 1A Warrants"); (iv) 15,656,242 Warrants with an exercise price of C$5.14 per Common Share (the "TerrAscend 1B Warrants"); (v) 2,225,714 Warrants with an exercise price of C$5.95 per Common Share (the "TerrAscend 2A Warrants"); (vi) 333,723 Warrants with an exercise price of C$6.49 per Common Share (the "TerrAscend 2B Warrants"); (vii) 1,926,983 Warrants with an exercise price of C$15.28 per Common Share (the "TerrAscend 3A Warrants"); and 178,735 Warrants with an exercise price of C$17.19 per Common Share (the "TerrAscend 3B Warrants", together with the TerrAscend 1A Warrants, TerrAscend 1B Warrants, the TerrAscend 2A Warrants, TerrAscend 2B Warrants and TerrAscend 3A Warrants, the "TerrAscend Warrants"). On October 24, 2022, Canopy Growth, certain of its wholly-owned subsidiaries and Canopy USA completed a series of transactions to effect a reorganization (the "Reorganization").

Canopy Growth Corporation and Canopy USA, LLC Announce Filing of Early Warning Report regarding TerrAscend Corp.

Canopy stock has been trending down for years, but shares surged Tuesday after it announced plans to consolidate its U.S. holdings.

Canopy Growth Looks South, as Canada Weed Sales Flatten

Canopy Growth Corporation (NASDAQ: CGC ) has spent most of 2022 on a downward trajectory. Despite some gains in March, it has been moving steadily downward amid macroeconomic headwinds and general market volatility.

5 Investors Betting Big on Canopy Growth (CGC) Stock

Canadian cannabis producer Canopy Growth Corp saw its shares soar 26.7% after announcing plans to create a holding company, Canopy USA LLC, aimed at speeding up its entry to the US, the world's largest and fastest growing cannabis market. Under the plans the company will buy partners Acreage Holdings Inc, Wana Brands and Jetty Extracts, deals that are expected to make Canopy profitable and give it a leading market share in the US.

Canopy Growth soars on plans to fast track entry to US cannabis market

Shares of cannabis companies shifted into rally mode on Tuesday after Canopy Growth Corp. CGC, +29.69% WEED, +25.08% revealed plans to create Canopy USA and issue exchangeable shares to consolidate its U.S. cannabis assets. Jefferies analyst Owen Bennett said the Canopy Growth deal "could also have positive implications for multi-state operators and paths to uplisting, potentially adopting similar structures.

Canopy Growth ignites rally in cannabis stocks

Canadian cannabis producer Canopy Growth (NASDAQ: CGC ) is in the headlines after agreeing to acquire the shares of Acreage (OTCMKTS: ACRHF ), a cannabis cultivation and retail company. This appears to be motivated by Canopy USA's strategy to gain a stronger foothold in the U.S. cannabis market.

Why Is Canopy Growth (CGC) Stock Up 25% Today?

Canadian cannabis company Canopy Growth said it's consolidating its U.S. assets into a single entity to accelerate its entry into the U.S. market.

Canopy Growth looks to speed up entry into U.S. cannabis market with new holding company

Ginkgo Bioworks Holdings

Revelation Biosciences

Penny stocks to watch with news today. The post 3 Hot Penny Stocks To Buy Under $3 With Must Read News appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

3 Hot Penny Stocks To Buy Under $3 With Must Read News

Canopy Growth Corp. said Tuesday it will no longer wait until federal legalization to buy three U.S. cannabis companies amid opportunities to benefit from strong growth in state-by-state cannabis sales.

Canopy Growth speeds up U.S. entry instead of waiting until federal cannabis legalization

Canopy Growth Corp. 's U.S.-listed shares CGC, -4.18% WEED, -2.78% rose 3.9% in premarket trades on Tuesday after the Canadian cannabis company announced a plan to consolidate its U.S. cannabis assets into a new holding company called Canopy USA. The holding company has an exchangeable share structure that is designed to trigger full ownership of U.S. cannabis investments and take advantage of U.S. cannabis market opportunities.

Canopy to fast-track entry into U.S. market

Cronos Group

Neptune Wellness Solutions Inc.

3 Marijuana Stocks That Hold Strong Market Potential The post 3 Marijuana Stocks That Could See More Gains Before November appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

3 Marijuana Stocks That Could See More Gains Before November

AdvisorShares Pure US Cannabis ETF

Trulieve Cannabis Corp.

It probably won't sink them alone, but it won't help much either.

Will the Federal Reserve Sink Cannabis Stocks, Or Will It Make Smart Investors Richer?

Creation of U.S. holding company and exchangeable share structure designed to enable Canopy USA to trigger full ownership of U.S. cannabis investments and capitalize on market opportunity projected to be over $50B 1 by 2026 Floating Share Arrangement Agreement facilitates acquisition of 100% of Acreage Holdings Additional balance sheet actions reduce costs and create flexibility to pursue strategic growth opportunities SMITHS FALLS, ON , Oct. 25, 2022 /PRNewswire/ - Canopy Growth Corporation ("Canopy" or the "Company") (TSX: WEED) (NASDAQ: CGC) today announced a strategy to accelerate its entry into the U.S. cannabis industry and unleash the value of its full U.S. cannabis ecosystem through the creation of a new U.S.-domiciled holding company, Canopy USA, LLC ("Canopy USA ") and the execution of a deliberate and highly-structured process. Canopy USA will hold the Company's U.S. cannabis investments, which will enable it to exercise rights to acquire Acreage (as defined below), Wana (as defined below) and Jetty (as defined below).

Canopy Growth to Fast Track Entry into the U.S. Cannabis Market

Aurora Cannabis

Tilray Brands

How bad is this news for marijuana stocks -- and why is it so bad?

Why Tilray, Canopy Growth, and Aurora Cannabis Stocks Just Dropped

Constellation Brands

The company took another mammoth impairment charge on the pot producer last quarter.

Why Constellation Brands Remains Bullish on Canopy Growth

Village Farms International

Are Canadian Pot Stocks Setting Up For Upside? The post 3 Canadian Marijuana Stocks To Watch Right Now appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

3 Canadian Marijuana Stocks To Watch Right Now

Green Thumb Industries Inc.

Two key tailwinds are pushing these beaten-down pot stocks higher today.

Why Aurora Cannabis, Canopy Growth, and Green Thumb Industries Are Marching Higher Today

Even if federal legalization happens, would that really make marijuana stocks good investments?

Why Aurora Cannabis, Canopy Growth, and Tilray Stocks Bounced Today

How much should adjusted EBITDA profitability matter to investors?

Which Company Will Become Profitable First: Canopy Growth or Aurora Cannabis?

These struggling stocks could soar if the U.S. legalizes marijuana in the near future.

Better Buy: Canopy Growth vs. Cronos Group

If you can tolerate the risk, buying pot stocks at a discount today could make for a tidy profit in the future.

Why Pot Stocks Could Be Your Best Bear Market Buy

Canadian weed companies have great staying power, a government data set reveals.

Why Canopy Growth and Tilray Blasted Higher Today

Innovative Industrial Properties

President Joe Biden's recent pronouncements shook the cannabis industry out of its slumber.

News for Canopy Growth Stock (CGC)